NCT00987870View on ClinicalTrials.gov

Safety and Efficacy of BFH772 in Psoriasis Patients

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

15

Participants

Timeline

Start Date

September 30, 2009

Primary Completion Date

February 28, 2010

Conditions
PsoriasisArthritis
Interventions
DRUG

BFH772

DRUG

Placebo

DRUG

BFH772

DRUG

Placebo

DRUG

calcipotriol/betamethasone

Trial Locations (1)

Unknown

Novartis Investigator Site, Berlin

Sponsors
All Listed Sponsors
lead

Novartis Pharmaceuticals

INDUSTRY